Bellevue, WA, United States of America

Arthur Yeung


Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2005-2008

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Mind of Arthur Yeung: A Pioneer in Immunomodulation

Introduction: Arthur Yeung, a distinguished inventor based in Bellevue, WA, has made significant strides in the field of pharmaceutical innovations. With a remarkable portfolio of two patents, he has focused on the synthesis and application of novel compounds that modulate the immune response, specifically targeting tumor necrosis factor (TNFα).

Latest Patents: Yeung's latest patents involve groundbreaking pharmaceutical compositions aimed at immunomodulation. The first patent details the synthesis and use of a novel class of TNFα inhibitors and immunomodulators. These compounds are designed to address a range of inflammatory, infectious, autoimmune, or other proliferative diseases associated with the activity of TNFα and other related cytokines. The structures of these compounds include variations where integers range from 0 to 12 for a, b, and c, and where specific groups can significantly enhance pharmacological applications.

Career Highlights: Throughout his career at Mediquest Therapeutics, Inc., Yeung has demonstrated a strong commitment to advancing pharmaceutical sciences. His work is not only innovative but also critical in developing therapies that can improve patient outcomes in various medical conditions linked to immune system dysfunction.

Collaborations: Arthur Yeung has had the pleasure of collaborating with notable professionals in the industry, including Mark R. Burns and Maralee McVean. These partnerships have contributed to the enriching environment at Mediquest Therapeutics, promoting a culture of innovation and excellence in research and development.

Conclusion: Arthur Yeung's contributions to the field of immunology and pharmacology underscore the importance of innovation in medicine. His patents reflect a dedication to improving therapeutic options for patients suffering from diseases related to TNFα and cytokine activity. As he continues his work at Mediquest Therapeutics, Yeung remains a vital figure in the world of pharmaceutical inventions, paving the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…